Wilmar International - RHB Invest 2019-05-16: Upbeat On 2Q19; Still Our Top Buy

WILMAR INTERNATIONAL LIMITED (SGX:F34) | SGinvestors.io WILMAR INTERNATIONAL LIMITED (SGX:F34)

Wilmar International - Upbeat On 2Q19; Still Our Top Buy

  • WILMAR INTERNATIONAL LIMITED (SGX:F34) remains our Top Pick for the plantation sector. Stay BUY with new Target Price of SGD3.94 from SGD3.80, 13% upside plus 3% yield.
  • Post analyst briefing, we are more upbeat on Wilmar's 2Q19 results. We believe the tropical oils should remain strong on low feedstock costs, while oilseeds & grains should improve, as soybean crush margins turn positive in the current quarter.



Crush margin turns positive.

  • According to management, soybean crush turns positive this quarter, as utilisation rate increases to c.80% from 50% in 1Q19. This is largely due to consolidation in the crushing industry following the outbreak of African swine fever and improving demand due to cheap soybean meal prices.
  • On top of that, Wilmar is likely to benefit from lower input costs, as Brazilian soybean prices have dropped 5% q-o-q and 18% y-o-y. The widening of Brazilian bean basis might also give a boost to Wilmar’s hedging gains.


Tropical downstream margins as beneficiary of low CPO prices.

  • For 2Q19, CPO prices have fallen 4% q-o-q and 18% y-o-y. The low price environment for CPO and weakening of MYR would continue to support the processing margins for tropical oils for this quarter.
  • We believe Wilmar's 3Q processing margins would still remain strong as well since the group is likely to stock up on the cheap inventories.


New CPO and PK price assumptions.

  • We have revised in-house CPO and PK price assumptions to MYR2,200, MYR2,400 and MYR2,500 per MT and MYR1,300, MYR1,550, MYR1,550 for FY19F-21F. This has tweaked our FY19F-21F earnings by -2% to 2%.
  • We also roll over our valuation base year to FY20F, resulting in a higher SOP-derived Target Price of SGD3.94.


IPO still on track.

  • Wilmar's China IPO remains a key catalyst to share price. The group is likely to submit its prospectus to the China Securities Regulatory Commission in July. Following which, management believes the authorities would take 2-4 months to approve.
  • Management expects the IPO of its China subsidiary to be completed in 2H19.





Juliana Cai CFA RHB Securities Research | https://www.rhbinvest.com.sg/ 2019-05-16
SGX Stock Analyst Report BUY MAINTAIN BUY 3.94 UP 3.800



Advertisement



MOST TALKED ABOUT STOCKS / REITS OF THE WEEK



loading.......



ANALYSTS SAY


loading.......